research Effect of Platelet-Rich Plasma on Diffuse Effluvium in Post-COVID-19 Infection
PRP treatment helps reduce hair loss in post-COVID-19 patients.
Search
for
Sort by
Research
480-510 / 1000+ results
research The Effectiveness of Microneedling in the Treatment of Post-COVID-19 Hair Disorders
Microneedling therapy is effective and safe for treating hair disorders worsened by COVID-19.
research Telogen Effluvium and Trichodynia in Different Severity Groups of Post COVID-19 Patients
Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.
research Case Report: Hair Care Routine to Treat Telogen Effluvium Associated With Post-COVID-19 Infection
A woman's COVID-19 related hair loss improved after using a specific hair care routine for 30 days.
research Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium
Effective hair regrowth after COVID-19 involves psychological support, good nutrition, and hair growth treatments.
research Telogen Effluvium Post COVID-19 Infection: A Narrative Review
COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.
research Herbal Medicine, Traditional Practice, and Nutraceutical as Prospective Alternative Therapy for Post COVID-19 Syndrome
Herbal medicine and nutraceuticals may help treat Post COVID-19 Syndrome, but more research is needed.
research Red Nail Bands in Conjunction with Telogen Effluvium as a Post-COVID-19 Phenomenon
Red stripes on nails and hair loss may occur after COVID-19.
research Evaluation of Post-COVID-19 Sequelae in Patients Attending a Pulmonology Clinic in the Metropolitan Region of Goiânia
Post-COVID-19 patients often experience musculoskeletal issues, fitness decline, behavioral changes, chest pain, cough, hair loss, and nervous system problems.
research Post-Covid Telogen Effluvium
COVID-19 may cause temporary hair loss, which usually gets better on its own, but reducing stress and managing health issues might help recovery.
research Is There a Post-COVID Dermatological Syndrome? The Integrated Dermato-Infectious Disease Experience of a Single Centre
There might be a skin condition related to COVID-19.
research Black Dots in Trichoscopy After COVID-19: Can It Be Telogen Effluvium?
A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.
research The Need to Analyze Telogen Effluvium and Alopecia Areata Parallelly in Long COVID Studies
Analyzing both TE and AA together is crucial for understanding post-COVID-19 hair loss.
research Prevalence of Hair Loss After COVID-19 Vaccination Among an Egyptian Population: A Cross-Sectional Study
About a quarter of the participants experienced hair loss after COVID-19 vaccination.
research Effect of COVID-19 Outbreak on Hair Transplant Field in India
The COVID-19 pandemic caused most hair transplant surgeons in India to stop working, and many planned to change their safety measures afterwards.
research Early-Onset Effluvium Secondary to COVID-19: Clinical and Histologic Characterization
COVID-19 can cause hair loss starting as early as 18 days after infection.
research Alopecia Areata Occurring After COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.
research The Association of Hair Loss and Coronavirus Infection COVID-19 – Facts and Hypotheses
COVID-19 may cause different types of hair loss, and the virus's effects on hair could help understand its impact on other body parts.
research Hair Loss Following COVID-19 Infection - The State of Current Knowledge and Treatment Approaches
COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.
research Telogen Effluvium After COVID-19 Infection: A Narrative Review of the Physiological Mechanism
COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.
research Therapy Experience in Alopecia After COVID-19
The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.
research Correlation of COVID-19 and Hairfall: A Cross-Sectional Study
COVID-19 is linked to temporary hair loss, especially in women.
research Telogen Effluvium and COVID-19: A Cross-Sectional Study
COVID-19 infection is highly related to increased hair loss, especially in women.
research Prevalence of Hair Loss in Egyptian People After COVID-19 Vaccination
Hair loss is not clearly linked to COVID-19 vaccination in Egyptians.
research Alopecia and COVID-19: Possible Etiopathogenetic Variants and Therapeutic Approach
COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.
research Reply to Early Onset Effluvium Secondary to COVID-19 and Body-Hair Effluvium
COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.
research Identifying Long-Term Effects of SARS-CoV-2 and Their Association with Social Determinants of Health in a Cohort of Over One Million COVID-19 Survivors
The research found that COVID-19 survivors experienced long-term effects like anemia and hypertension, with age and gender being important factors, but race, income, and education had little to no impact.
research Why We Should Treat COVID-19 Long Hauler Syndromes with Convalescent Plasma; Contained Suppressive Exosomes Are Likely COVID Antigen-Specific
The document suggests using convalescent plasma to treat COVID-19 Long Hauler Syndromes because it may contain beneficial elements that target the virus.
research Factors Associated with Acute Telogen Effluvium and COVID-19 Infection
This study investigates the prevalence and factors associated with Acute Telogen Effluvium (TE) in COVID-19 patients. Conducted at Sohail Trust Hospital in Karachi, the study involved 100 COVID-19 PCR-positive patients from January to July 2022. Results showed that 64% of female participants experienced TE post-COVID-19, with diabetes being the most common co-morbidity. The temporal region was the most affected area, and lack of dietary supplements was linked to severe hair loss. Additionally, 34.6% of those with hair loss reported similar issues in family members post-COVID-19. Only 7% sought professional treatment, highlighting the need for greater awareness and treatment accessibility for TE in COVID-19 survivors.
research Change of the Diagnostic Distribution in Applicants to Dermatology After COVID-19 Pandemic: What It Whispers to Us?
The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.